May 27, 2026 08:00AM
May 15, 2026 04:05PM
Jan 17, 2026 08:00AM
Nov 20, 2025 08:00PM
Nov 20, 2025 08:00PM
Oct 31, 2025 09:20AM
Oct 30, 2025 11:02PM 4DMT partners with Otsuka for $85M upfront on Asia-Pacific drug deal
Oct 30, 2025 11:02PM
Oct 14, 2025 08:00AM
May 5, 2025 08:00AM
May 1, 2025 08:01AM
May 1, 2025 08:00AM
Mar 27, 2025 08:00AM
Feb 19, 2025 08:00AM 4DMT to Participate in Upcoming Investor Conferences
Feb 8, 2025 02:30PM
Jan 29, 2025 08:00AM
Jan 10, 2025 08:07AM
Jan 10, 2025 08:00AM
Sep 19, 2024 08:06AM
Jun 8, 2024 04:30PM
Mar 28, 2024 01:32PM 4D Molecular Therapeutics (FDMT) PT Lowered to $63 at BMO Capital, 'uncertainty remains a lingering overhang until the PhIII readout'
Feb 7, 2024 05:33AM
Feb 7, 2024 05:21AM
Feb 6, 2024 11:27PM
Feb 5, 2024 04:05PM
Feb 5, 2024 04:05PM
Feb 5, 2024 05:44AM
Feb 3, 2024 05:00PM 4DMT Presents Positive Interim Data from Randomized Phase 2 PRISM Clinical Trial of Intravitreal 4D-150 Demonstrating Favorable Tolerability & Clinical Activity in Wet AMD
Jan 29, 2024 08:00AM
Jan 23, 2024 08:07AM
Nov 9, 2023 04:19PM
Oct 30, 2023 08:01AM
Oct 30, 2023 08:00AM
Jul 31, 2023 05:41AM
Jul 29, 2023 12:00PM 4DMT Presents Additional Positive Interim Data from Intravitreal 4D-150 Phase 1/2 PRISM Clinical Trial in Patients with Wet AMD at ASRS 2023
Jul 10, 2023 07:30PM
Jul 5, 2023 05:35AM
Jun 7, 2023 04:10PM
Jun 7, 2023 04:10PM
Jun 1, 2023 08:00AM
May 11, 2023 08:00AM
May 11, 2023 08:00AM 4DMT Announces Presentation on Aerosolized 4D-710 for Treatment of Cystic Fibrosis at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting
May 9, 2023 04:05PM
May 8, 2023 04:05PM
May 5, 2023 05:43AM
May 4, 2023 09:04PM
May 4, 2023 04:09PM
May 4, 2023 04:08PM
Apr 27, 2023 07:00AM 4D Molecular Therapeutics (FDMT) Reports Positive Interim Data from Intravitreal 4D-150 Phase 1/2 PRISM Clinical Trial
Apr 27, 2023 07:00AM

323,731 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All